CAR-T cell therapy, originally developed for cancer, is showing ever more promise as a treatment for autoimmune diseases.
The new data bolster Allogene’s efforts to develop a new, easily administered cell therapy that could delay or prevent cancer recurrence.
Mary Bird Perkins Cancer Center in Baton Rouge, Louisiana is offering a CAR-T cell-based immunotherapy, which genetically ...
CAR-T cell therapy, originally developed for cancer, is showing ever more promise as a treatment for autoimmune diseases.
Since 2017, a personalized immunotherapy called Chimeric Antigen Receptor, or CAR-T cell treatment, has worked wonders to ...
Cancers that were once considered incurable now have new treatment options. Among these innovations are CAR-T (chimeric ...
A New Hope for Patients with Advanced Gastric and Pancreatic Cancers SHANGHAI, April 9, 2026 /PRNewswire/ -- A groundbreaking new CAR-T cell therapy for advanced gastrointestinal cancers is expected ...
IFLScience on MSN
CAR-T therapy is revolutionizing cancer treatment. Next on the list: autoimmune disease
A woman who had been sick for many years with three autoimmune conditions has experienced a remarkable recovery after being ...
Initial results from a high-stakes trial indicate the biotech may have finally found a niche in lymphoma care for a ...
New Scientist on MSN
CAR T-cell therapy takes woman from bedridden to 'perfectly fine'
A woman with three different autoimmune conditions had all of them treated simultaneously by genetically modifying her immune ...
Anne Jordan was diagnosed with blood cancer in 2016. After multiple treatments of chemotherapy and radiation, her doctors recommended she consult Dr. Nakhle Saba, director of the CAR-T program at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results